Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 233 - Carboxylic acid amides
Patents for C07C 233 - Carboxylic acid amides (28,881)
01/2006
01/05/2006US20060004062 Compounds for inhibiting insulin secretion and methods related thereto
01/05/2006CA2584502A1 2-methylpropanamides and their use as pharmaceuticals
01/05/2006CA2572153A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
01/04/2006EP1611096A2 Benzamide modulators of metabotropic glutamate receptors
01/04/2006EP1611086A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
01/04/2006EP1611085A1 Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors
01/04/2006EP1611084A1 Process for the manufacture of n-alkoxalyl-alaninates
01/03/2006US6982349 etherification of 2-(4-hydroxyphenyl)acetamide with (R)-epichlorohydrin in presence of an alkali metal hydroxide and quaternary ammonium salt as a phase transfer catalyst; decyclization and amination with isopropylamine
01/03/2006US6982348 for example, N[(1RS2SR)-2-(4-fluorophenyl)-2-hydroxy-1-[4-fluoromethyl)benzyl]ethyl]-6,7-dihydro-5H-benzo[a]cycloheptene-1-carboxamide; cholesteryl ester transfer protein inhibitory action; lipid-lowering agents
01/03/2006CA2244695C Cyclic amic acid derivatives
12/2005
12/29/2005WO2005085189A3 Analogues of congo red and evaluation of their anti-prion activity
12/29/2005WO2005077122A3 Compounds and compositions as lxr modulators
12/29/2005WO2005009104A3 Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
12/29/2005WO2004092122A3 Preparation and purification of synthetic capsaicin
12/29/2005US20050288523 Chiral diphosphorus compounds and transition metal complexes thereof
12/29/2005US20050288338 Amido compounds and their use as pharmaceuticals
12/29/2005US20050288329 2-(4-Chlorophenyl)-N-[(1R,2R)-2-(benzyloxy)cyclohexyl]-2-methylpropanamide; modulators of 11- beta hydroxyl steroid dehydrogenase type 1 and/or mineralocorticoid receptor
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/29/2005US20050287108 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
12/29/2005CA2570248A1 Polycationic compounds and uses thereof
12/29/2005CA2568539A1 Small molecules for treatment of hypercholesterolemia and related diseases
12/28/2005EP1608339A1 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
12/28/2005EP1299352B1 Compounds to treat alzheimer's disease
12/28/2005EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
12/28/2005CN1234189C Molecular gel electrolyte and its prepn
12/28/2005CN1233621C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
12/27/2005US6979750 Drug treating positive inotropic on the heart without affecting the heart rate, lowing body temperature, diseases caused by G protein coupled receptor, like congestive heart failure, bipolar disorder, depression, schizophrenia, eating disorders
12/27/2005US6979749 from non-carcinogenic raw materials, employing Suzuki type biaryl coupling as key step; use of palladacycle as catalyst with turnover number in the range of 6 to 10.
12/27/2005US6979744 Dimer amidopropyl dimethyl betaines
12/27/2005US6979566 Method of treatment of viral infection including HIV using water soluble fullerenes—III
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121117A1 Processes for production of optically active compounds
12/22/2005WO2005121071A1 Process for the preparation of nateglinide
12/22/2005WO2005120477A2 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators
12/22/2005WO2005113558A3 Simple stereocontrolled synthesis of salinosporamide a
12/22/2005WO2005061443A3 Benzoyl-substituted phenylalanine amides
12/22/2005WO2004098512A3 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
12/22/2005US20050283019 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
12/22/2005US20050283011 Method of forming amides from fatty acid and urea in the presence of catalyst with heating. Solvent extraction with chloroform and treatment with hexane, ethanol and acetonitrile
12/22/2005US20050282900 Inhibitors of alpha4 mediated cell adhesion
12/22/2005US20050282822 Therapeutic agents
12/22/2005CA2570041A1 Process for the preparation of nateglinide
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/21/2005EP1606244A2 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant
12/21/2005EP1605956A1 Administration of capsaicinoids
12/21/2005EP1090007B1 Cinoxacin lanthanide chelates and their use as biomolecular probes
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/21/2005CN1711235A New phenyl-naphthalene derivatives, and preparation method and drug containing same
12/21/2005CN1711234A Use of trans-pellitorin in the form of an aromatic substance
12/21/2005CN1232511C Process for preparing oxazolyl acetate derivative and its salts
12/21/2005CN1232502C Process for producing nateglinide crystal
12/20/2005US6977303 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
12/15/2005WO2005118526A1 Organic activator
12/15/2005WO2005117907A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
12/15/2005WO2005117854A2 Aryl ketone compounds and compositions for delivering active agents
12/15/2005US20050277788 Process for preparing phthaloyl chloride
12/15/2005US20050277681 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005DE4328950B4 N-Vinylformamid-Zubereitung und deren Verwendung N-vinylformamide preparation and use thereof
12/15/2005DE19507294B4 Verfahren zur Herstellung und Reinigung iodierter Kontrastmittel A process for the preparation and purification of iodinated contrast agents
12/15/2005DE102004025072A1 Verfahren zur Herstellung von Diphenyl-azetidinon-Derivaten Process for the preparation of diphenyl-azetidinone derivatives
12/15/2005CA2567353A1 Organic activator
12/15/2005CA2566161A1 Aryl ketone compounds and compositions for delivering active agents
12/14/2005EP1604212A2 Modulators of the g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
12/14/2005EP1603864A2 Diphenylethylene compounds and uses thereof
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005EP1066258B1 Aryl phenyl substituted cyclic ketoenols
12/14/2005CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
12/14/2005CN1231462C Production process of dialkyl formamide
12/14/2005CN1231460C Process for the preparation of (R)-or (S)-aminocarnitine inner salt, the salts and derivatives thereof
12/14/2005CN1231456C Process for preparing optically active cyclopropyl carboxylic acid derivative
12/14/2005CN1231440C Novel tricyclic compound
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/13/2005US6974827 For use as pesticides and herbicides
12/08/2005WO2005115994A1 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof
12/08/2005WO2005034940A3 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/08/2005US20050272954 Synthesis of ynamides
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272815 Compounds and compositions for delivering active agents
12/08/2005US20050272638 Improved bioavailability; for oral and intracolonic administration
12/08/2005US20050272631 able to be employed in colder solutions; cleaning products
12/08/2005US20050272036 Ketones
12/08/2005DE102004024807A1 Verfahren zur Herstellung von Phthalsäuredichlorid A process for preparing phthaloyl chloride
12/08/2005DE102004023508A1 Säurederivate substituierter Cyclohexyl-1,4-diamine Acid derivatives substituted cyclohexyl-1,4-diamine
12/08/2005DE102004022900A1 Chirale Diphosphorverbindungen und deren Übergangsmetallkomplexe Chiral diphosphorus and their transition metal complexes
12/08/2005DE102004022898A1 Chirale Diphosphinoterpene und deren Übergangsmetallkomplexe Chiral Diphosphinoterpene and their transition metal complexes
12/07/2005EP1601641A2 Substituted anilide ligands for the thyroid receptor
12/07/2005EP1296994B1 Ferrocenyl diphosphines and their use
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005CN1705635A Inhibitors of histone deacetylase
12/07/2005CN1704421A Cirality diphosphaneterpene and transition metal complex thereof
12/06/2005US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders
12/06/2005US6972300 Compounds and compositions for delivering active agents
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972287 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/06/2005US6972111 Rosin amine anti-fouling agents
12/06/2005CA2268910C Asymmetrical imide bleach activators and compositions employing the same
1 ... 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 ... 289